Search results
- 105.25Add to watchlist+1.00 (+0.96%)As of Thu. May 30, 2024 10:58 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open104.58High105.25Low103.70
- Mkt Cap6.63BP/E (TTM)21.79Div & YieldN/A & N/A
- Prev. Close104.2552 Wk. Low103.0152 Wk. High146.70
What analysts are sayingTop stories3 Cheap Blue-Chip Stocks to Buy Now: May 2024Yahoo Finance · 2 weeks agoRelated stocks
19 hours ago · Jazz Pharmaceuticals is a biopharmaceutical company that develops and commercializes products for various neurological and oncology conditions. See its stock price, financial results, news, events, and analyst ratings on Stock Analysis.
5 days ago · The high in the last 52 weeks of Jazz Pharmaceuticals stock was 146.47. According to the current price, Jazz Pharmaceuticals is 72.41% away from the 52-week high. What are analysts forecasts...
People also ask
Which companies do Jazz Pharmaceuticals investors own?
How much is Jazz Pharmaceuticals stock worth?
How far is Jazz Pharmaceuticals stock from the 52-week low?
What is Jazz Pharmaceuticals price target?
May 3, 2015 · 13 analysts have issued 12 month target prices for Jazz Pharmaceuticals' stock. Their JAZZ share price targets range from $131.00 to $230.00. On average, they predict the company's stock price to reach $192.75 in the next twelve months. This suggests a possible upside of 83.5% from the stock's current price.
- investorinfo@jazzpharma.com
May 23, 2024 · Jazz Pharmaceuticals PLC. + Add to watchlist. JAZZ:NSQ. Actions. Price (USD) 103.94. Today's Change -1.57 / -1.49% Shares traded 796.30k. 1 Year change -20.28% Beta 0.6155. Data delayed at least...
- 108.27
- 108.88
- 111.35
- 109.27
3 hours ago · Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Companyâ s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn ...
May 20, 2024 · Jazz Pharmaceuticals plc (JAZZ.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Jazz Pharmaceuticals plc | Nasdaq: JAZZ | Nasdaq.
6 days ago · Updated May 24, 2024. 3M - 20.12% JAZZ Price. $106.06. Fair Value Price. N/A. Market Cap. $6.69B. 52 Week Low. $103.01. 52 Week High. $146.70. P/E. 20.28x. P/B. 1.81x. P/S. 1.96x. PEG. 0.26x. Dividend Yield. N/A. Revenue. $3.84B. Earnings. $330.79M. Gross Margin. 89.5% Operating Margin. 13.51% Profit Margin. 8.6% Debt to Equity. 2.06.